Ivermectin, ‘wonder drug’ from Japan : (Record no. 3710)

000 -LEADER
fixed length control field 01787nam a22002057a 4500
003 - CONTROL NUMBER IDENTIFIER
control field DOH
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210322102422.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210322b ||||| |||| 00| 0 eng d
245 00 - TITLE STATEMENT
Title Ivermectin, ‘wonder drug’ from Japan :
Remainder of title the human use perspective /
Statement of responsibility, etc. Andy Crump and Satoshi Ōmura
520 3# - SUMMARY, ETC.
Summary, etc. Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin—originating solely from a single microorganism isolated at the Kitasato Intitute, Tokyo, Japan from Japanese soil—has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world’s most devastating and disfiguring diseases which have plagued the world’s poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin’s passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a “wonder” drug.
580 ## - LINKING ENTRY COMPLEXITY NOTE
Linking entry complexity note Proc. Jpn. Acad., Ser. 2011 87 (2) pages 13-28
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ivermectin
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Elephantiasis, Filarial
General subdivision drug therapy
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Crump, Andy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ōmura, Satoshi
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/pdf/pjab-87-013.pdf">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/pdf/pjab-87-013.pdf</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
999 ## -
-- 3710
-- 3710
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    National Library of Medicine     DOH Central Library DOH Central Library Electronic Resource Section 03/22/2021   J000260 D0001J000260 03/22/2021 03/22/2021 Journal Article